History
  • No items yet
midpage
176 F. Supp. 3d 305
S.D.N.Y.
2016
Read the full case

Background

  • IBD (Innovative Biodefense) purchased assets and sublicense rights to antimicrobial formulas (originally licensed from Columbia University to VSP) from BDS under a June 1, 2011 Asset Purchase Agreement; dispute centers on whether IBD assumed BDS’s past-due royalty obligations.
  • VSP granted three nearly identical Sublicense Agreements to BDS (2009) obligating VSP to “make available” Know-How useful or necessary to utilize the patented technology; BDS was responsible for development, manufacturing, and regulatory compliance.
  • Disagreement over scope and sufficiency of “know-how”: IBD says VSP withheld critical manufacturing/quality documents and that provided materials were insufficient to produce FDA-compliant products; VSP/BDS contend VSP provided formulas and technical materials.
  • After the Asset Purchase, IBD paid some funds but stopped paying ongoing royalties; VSP and Micceri (VSP president) counterclaimed for breach and related relief; Micceri also sued individually.
  • IBD moved for summary judgment to dismiss many counterclaims; defendants cross-moved for summary judgment on some counterclaims. The court granted in part and denied in part: dismissed unjust enrichment and several abandoned counterclaims and all individual claims against Micceri; denied summary judgment on breach of contract and fee claims and denied defendants’ cross-motion in its entirety.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether VSP breached the Sublicense Agreements by failing to make required know‑how available VSP had broad duty to provide all information "useful or necessary" (including manufacturing/quality docs); it withheld key materials so IBD could not make compliant products, excusing IBD’s performance VSP provided formulas and technical materials in its control; BDS/IBD were responsible for product development and regulatory compliance Genuine disputes of material fact exist as to scope/sufficiency of know‑how and materiality of any breach; summary judgment denied on breach counterclaim
Whether IBD assumed BDS’s past‑due royalty obligations under the Asset Purchase Agreement IBD contends it assumed limited liabilities; payment of $250k was conditional on a negotiated settlement that never occurred, so no obligation to pay past royalties Defendants say IBD assumed BDS’s liabilities including past royalties Material factual disputes about the APA’s terms and the Memorandum of Understanding preclude summary judgment for defendants
Unjust enrichment claim by VSP against IBD N/A (defendants alleged unjust enrichment because IBD continued using technology without paying royalties) VSP claims IBD has been enriched at VSP’s expense and should pay continuing royalties Court: unjust enrichment barred where a valid contract governs the subject matter; IBD’s motion granted to dismiss unjust enrichment claim
Individual liability of Micceri for corporate obligations and torts IBD contends Micceri personally interfered with access to know‑how and can be liable (including under alter‑ego and direct tort theories) Defendants argue Micceri isn’t a party to sublicenses and cannot be personally liable absent veil piercing Court denied summary judgment for defendants: factual disputes exist on whether Micceri dominated VSP (alter ego) and whether he personally interfered; however, all claims asserted solely in Micceri’s individual capacity (as pleaded by defendants) were dismissed for lack of standing/real party in interest
Fraud/negligent misrepresentation re: $48,000 payment to Micceri IBD says payment was for know‑how and was conditioned on a signed letter; defendants say it paid outstanding consulting fees Defendants attribute most misrepresentations to Berkowitz, not Micceri; dispute over who directed payment and representations given Court found disputed facts (contradictory testimony) sufficient to deny summary judgment on these claims against Micceri

Key Cases Cited

  • Senno v. Elmsford Union Free Sch. Dist., 812 F. Supp. 2d 454 (S.D.N.Y. 2011) (summary judgment standard and genuine issue of material fact explained)
  • Reeves v. Sanderson Plumbing Prods., 530 U.S. 133 (U.S. 2000) (credibility determinations and weighing evidence are for the jury)
  • Merrill Lynch & Co., Inc. v. Allegheny Energy, Inc., 500 F.3d 171 (2d Cir. 2007) (material breach and substantial performance principles)
  • Galli v. Metz, 973 F.2d 145 (2d Cir. 1992) (contract interpretation avoids rendering clauses superfluous)
  • Briarpatch Ltd., L.P. v. Phoenix Pictures, Inc., 373 F.3d 296 (2d Cir. 2004) (elements of unjust enrichment under New York law)
  • Carte Blanche PTE., Ltd. v. Diners Club Int’l, Inc., 758 F. Supp. 908 (S.D.N.Y. 1991) (veil‑piercing is fact intensive and usually for the jury)
  • In re Parmalat Sec. Litig., 375 F. Supp. 2d 278 (S.D.N.Y. 2005) (alter‑ego/veil‑piercing factors and standards)
  • American Protein Corp. v. AB Volvo, 844 F.2d 56 (2d Cir. 1988) (veil‑piercing generally a fact question)
  • Redd v. New York Div. of Parole, 678 F.3d 166 (2d Cir. 2012) (credibility determinations belong to the jury)
Read the full case

Case Details

Case Name: Innovative Biodefense, Inc. v. VSP Technologies, Inc.
Court Name: District Court, S.D. New York
Date Published: Mar 31, 2016
Citations: 176 F. Supp. 3d 305; 2016 WL 1301179; 12 Civ. 3710 (ER)
Docket Number: 12 Civ. 3710 (ER)
Court Abbreviation: S.D.N.Y.
Log In
    Innovative Biodefense, Inc. v. VSP Technologies, Inc., 176 F. Supp. 3d 305